Keywords: alizyme, ends, enrollment, obesity, trial, completed, all

Alizyme ends enrollment in obesity trial

Article | 10 March 2003

Print This

Alizyme has completed enrollment of all 370 patients in its Phase IIBclinical trial of ATL-962 for the treatment of obesity. ATL-962 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in